Fibrillolysis

Fibrillolysis is the process of breakdown of protein fibers in the human body. This occurs during aging and is one of the signs of aging.

Fibrillolysis occurs in various diseases, such as atherosclerosis, diabetes mellitus, rheumatoid arthritis and others. It can also be caused by long-term use of certain medications, such as antibiotics or hormones.

Symptoms of fibrillolysis may include dry skin, wrinkles, hair loss and other signs of aging. However, if you start treatment on time, you can slow down the aging process and maintain healthy skin and hair.

Various methods are used to treat fibrillolysis, such as hyaluronic acid injections, laser procedures, massage and others. It is important to remember that treatment must be comprehensive and carried out under the supervision of a specialist.

Fibrillolysis (from Latin fibrillōsis - fibrous and Greek λύσις - decomposition, decay) is the process of destruction or splitting of thin fibers, for example, in tissues and organs; in particular, fibrillolysis is the process of splitting fibrin fibers that form the basis of a blood clot.

Fibrillolysis is one of the stages of the inflammation process. It begins after activation of the complement system, which leads to the formation of an antigen-antibody complex. This complex causes the activation of blood clotting factors such as thrombin and von Willebrand factor. As a result of this process, fibrin fibers are formed, which form the basis of the blood clot and protect the damaged area from further bleeding.

However, if fibrinolysis occurs too quickly, this can lead to the development of hemorrhagic syndrome, which is characterized by the formation of multiple small hemorrhages. In addition, fibrinolytic processes can lead to the destruction of atherosclerotic plaques and thrombotic masses in blood vessels, which can cause the development of thromboembolism.

To prevent fibrinolysis, various drugs are used, such as heparin and its analogues, as well as fibrin-stabilizing drugs. Also, to prevent fibrinolysis, drugs that inhibit the activity of the complement system can be used.